WWS 597 Reinhardt

THE HEALTH CARE SYSTEMS OF GERMANY AND

Merely slouching towards “Regulated Competition” SOCIAL WITH PRIVATE PURCHASING THE FINANCING OF HEALTH CARE

SOCIAL PRIVATE NO INSURANCE OWNERSHIP INSURANCE OF PROVIDERS (Ability-to-Pay Financing) (Actuarially fair premiums)

Single Multiple Non- For- Out-of- Payer Carriers Profit Profit pocket

Government A D G J M

Private, but non-profit B E H K N

Private, and commercial C F I L O First, some comparative statistics 8000

7000

International Comparison of Spending on Health, 1980–2007 6000 Average spending on health per capita ($US PPP) 5000 U.S.

4000 Switzerland 3000 Germany

2000

1000 0 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007

Source: OECD Health Data 2009 (June 2009) cited in http://www.commonwealthfund.org/Content/Publications/Chartbooks/2009/Multinational-Comparisons-of-Health-Systems- Data-2009.aspx 16

15

14

International13 Comparison of Spending on Health, 1980–2007 Total expenditures on health 12 as percent of GDP

U.S. 11 Switzerland

10 Germany

9 Netherlands 8

7

6

5 005 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2 2006 2007

Source: OECD Health Data 2009 (June 2009) cited in http://www.commonwealthfund.org/Content/Publications/Chartbooks/2009/Multinational-Comparisons-of-Health-Systems- Data-2009.aspx Percentage of Population over Age 65 Percent with Influenza Immunization, 2007 80 77.5 77.0 73.5 69.0 70 66.7 64.9 64.3 63.7 58.9 60 56.0 56.0

50

40

30

20

10

0 a AUS* NETH UK FR US ITA CAN NZ OECD GER SWITZ Median

* 2006 Source: OECD Health Data 2009 (June 2009). Obesity (BMI>30) Prevalence Among Adult Percent Population, 2007 34.3 35

30 26.5

25 24.0

20

15.4 15 13.6 11.2 10.5 10.2 9.9 9.0 10 8.1

5

0 US* NZ UK CAN GER** NETH FR* SWE ITA NOR SWITZ * 2006 ** 2005 Note: BMI = body mass index. For most countries, BMI estimates are based on national health interview surveys (self-reported data). However, the estimates for the US, UK, and New Zealand are based on actual measurements of weight and height, and estimates based on actual measurements are usually significantly higher than those based on self-report. Source: OECD Health Data 2009 (June 2009). Potential Years of Life Lost Because of Diabetes per 100,000 Population, 2007 99 100

80

64

60

40 37 36 36 35 33 31 29 25 19 20

0 US** NZ** NOR* SWE* OECD GER* NETH ITA* FR* UK SWITZ* Median

* 2006 ** 2005 Source: OECD Health Data 2009 (June 2009). Health Care Expenditure per Capita by Source of Funding, 2008 Dollars In Purchasing‐Power Parity Dollars (PPP $s) 8,000 $7,538 Out-of-pocket spending 7,000 912 Private spending Public spending 6,000

$5,003 5,000 3,119 $4,627 756 $4,029 35 $3,796 $3,737 4,000 1,424 600 273 $3,472 $3,362 487 $3,319 648 543 616 382 605 3,000 467 88 347 197 494 2,000 4,213 3,507 2,863 2,875 2,869 2,736 2,841 2,585 1,000 2,263

0 US NOR SWITZ CAN FR GER SWE AUS* UK * 2007 SOURCE: OECD DATA BASE 2010, cited in Anderson and Markovich, “Multinational Comparisons of Health Systems Data, 2010, Commonwealth Fund International Symposium, 2010. Out‐of‐Pocket Health Care Spending per Capita, 2008 In Purchasing‐Power Parity Dollars (PPP $s) Dollars $1,600 $1,500 $1,424 $1,400 $1,300 $1,200 $1,100 $1,000 $912 $900 $800 $756 $700 $600 $605 $543 $600 $492 $487 $500 $372 $347 $400 $273 $300 $232 $200 $100 $0 SWITZ US NOR CAN AUS SWE OECD GER NZ UK FR NETH 2006 Median

SOURCE: OECD DATA BASE 2010, cited in Anderson and Markovich, “Multinational Comparisons of Health Systems Data, 2010, Commonwealth Fund International Symposium, 2010. Hospital Discharges per 1,000 Population, 2007

300 274

250 227

200 172 166 165 163 162 150 139 135 126 126 109

100 84

50

0 FR GER NOR SWITZ SWE OECD AUS* ITA* NZ US* UK NETH CAN* Median

* 2006 Source: OECD Health Data 2009 (June 2009). Number of Practicing Physicians per 1,000 Population, 2007

4 3.9 3.9 3.9 3.7 3.6 3.5 3.4 3.2

3 2.8 2.5 2.4 2.3 2.2

2

1

0 NETH NOR SWITZ ITA SWE* GER FR OECD AUS* UK US NZ CAN Median

* 2006 Source: OECD Health Data 2009 (June 2009). Pharmaceutical Spending per Capita, 2007 Dollars Adjusted for Differences in Cost of Living 900 $878

800

$691 700

$588 600 $542 $518 500 $454 $446 $446 $431 $422 $381 400

300 $241

200

100

0 US CAN FR GER ITA SWITZ SWE OECD AU S* N ET H N O R N Z Median

* 2006 Source: OECD Health Data 2009 (June 2009). Drug Prices for 30 Most Commonly Prescribed Drugs, 2006–07 1.00 1.0 US is set at 1.0

0.8 0.77 0.76

0.63 0.6 0.51 0.49 0.45 0.44

0.4 0.34

0.2

0.0 US CAN GER SWITZ UK AUS NETH FR NZ

Source: IMS Health. Drug Prices: Lipitor (atorvastatin), 2006–07 Dollars Price for one dose $3 $2.82

$2 $1.83

$1.52 $1.46 $1.45 $1.45 $1.35

$1.01 $1 $0.71

$0 US CAN SWITZ AUS UK NETH GER FR NZ

Source: IMS Health. Drug Prices: Nexium (esomeprazole), 2006–07 Dollars Price for one dose $4 $3.91

$3

$2.15 $1.97 $2

$1.32 $1.28 $1.22 $1.02 $1 $0.88

$0 US SWITZ CAN UK NETH FR AUS GER

Source: IMS Health. Magnetic Resonance Imaging (MRI) Machines per Million Population, 2007 30

25.9

20 18.6

14.4

10 8.8 8.5 8.2 8.2 6.7 6.6 5.7 5.1

0 US ITA SWITZ NZ OECD G ER U K C AN N ET H * * FR AU S Median

** 2005 Source: OECD Health Data 2009 (June 2009). MRI Scan and Imaging Fees, 2009 Dollars 1,400

1,200 1,200

1,000

839 824 800

567 600 436

400

179 200

0 US GER CAN NETH FR UK

Source: International Federation of Health Plans, 2009 Comparative Price Report. Coronary Bypass Procedures per 100,000 Population,

150 2007

132

125

100 85 81 77 76 73 73 75 59 58 56

50 45

32 31

25

0 GER US* NOR* NZ AUS* ITA* CAN* OECD NETH SWE UK FR SWITZ Median

* 2006 Source: OECD Health Data 2009 (June 2009). A closer look at German health care THE HEALTH INSURANCE SYSTEM OF GERMANY

A health‐are system with the following features

1. Mandated, universal health insurance (about 90% in the non‐ profit, private, Statutory Health Insurance (SHI) system (initiated by Chancellor Otto von Bismarck in the late 1880s), and about 10% with highly regulated for‐profit private insurers. 2. A mixed public‐private delivery system with a heavy for‐profit component, even among hospitals. 3. Overall pervasive and tight government regulation at both the state and federal levels. 4. By American standards, relatively low cost.

THE STATUTORY HEALTH INSURANCE SYSTEM OF GERMANY

The system grew out of the self‐help “friendly societies” established by workers during the industrialized revolution of the 1880s. Became a federal system in 1998 with Bismarck’s RVO –the Reichs‐versicherungsverordnung (Imperial Insurance Decree) which survives, after a myriad amendments over time to this day. Originally composed of over 1,000 quasi‐private, non‐profit sickness funds with what is called “self‐regulation”, but only within the very narrow limits allowed by the RVO. THE STATUTORY HEALTH INSURANCE SYSTEM OF GERMANY

Up to an income threshold that has changed over time (currently $62,500), all employed Germans were mandated to be insured under the SHI. Above the threshold people were free to choose private insurance or remain in the SHI or go without insurance. Until very recently (starting in 1992 and fully since 2004) people in the SHI did not have a choice of sickness plans, but instead were assigned to it on the basis of either craft, employer or location. Until 2004, the payroll contributions to the SHI (shared 50:40 by employers and employees) varied enormously among funds, which brought on the reforms of 2004. THE STATUTORY HEALTH INSURANCE SYSTEM OF GERMANY

Since 2004, Germans can choose among any of the 200 or so surviving sickness funds, at a uniform payroll tax, which covers the employee and dependent non‐working spouse, but not children, whose premiums are paid by the federal government. Unlike in the US, where patients often are confined to networks of providers, Germans have long enjiyed completely free choice of providers. Premiums paid by the insured now flow through the system as follows: Premiums Central health for Fund Children Federal (Risk Equalization Fund Government

Uniform payroll contribution of Risk adjusted capitation about 15% (and growing) of gross to sickness fund chosen wages shared by employer and by the insured employee

~ 160 non-profit Adult Insured Sickness Funds (Insurers)

C o For unemployed people -P DGRs for hospitals; capital from state ays the Unemployment FFS for ambulatory physicians Insurance fund pays the premiums. Refrence prices for pharmacies For retired people, their pension fund pays 50% Providers of Health of their premiums; they Care the rest. Self-Governance under Germany‘s Statutory Health Insurance

Federal Ministry of Health

Regulation & supervision

Patient

Federal Physicians‘ Chamber (BÄK) 150,000 Federal German Hospital 2,100 hospitals physicians and Association of SHI All physicians Federation psychotherapists Physicians (KBV) (DKG) 160 sickness funds Federal Association of Sickness Funds

Federal Joint Commitee (G-BA)

Institute for Quality and Efficiency in Institute for Quality (focused on Healthcare (IQWiG) - technologies providers)

Source: Reinhard Busse. For a more detailed chart on governance, see a separate handout. THE PRIVATE HEALTH INSURANCE SYSTEM OF GERMANY Provides full covers less than 10% of the German insurance, but supplemental coverage to millions of SHI insured (mainly for better amenities). Premiums at time of enrollment are actuarially fair, but thereafter can change by age, regardless of health status. Premiums are per individual, not per family.

Pay higher fees to physicians, but also registers higher health spending per capita. People who opt for private insurance cannot ever return to SHI unless they are poor. The industry is heavily regulated by the federal government, which sets the fee schedule (e.g., age reserves). HEALTH‐CARE DELIVERY SYSTEM OF GERMANY

Until very recently, there had been a strict division between ambulatory and inpatient care. Hospitals give only limited outpatient care. Hospital‐based physicians are (rather poorly paid) salaried employees of the hospital whose salary is included in the DRGs. Ambulatory physicians are self‐employed business people who practice in solo (75%) or group (25%) practices. The insured may voluntarily enroll in GP gatekeeper models at favorable premiums. PAYMENT OF HOSPITALS IN GERMANY

Germany has what is called a “dual hospital financing system.”

The states (Länder) pay for the structures and equipment of hospitals, within regional health planning), as role the states have jealously preserved for themselves. The hospital’s operating costs are covered by some 12,00 DRGs paid by the sickness fund, traditionally within a global budget per hospital, but not any more since 2009.

There exists in Germany a new Hospital Payment Institute that updates the DRGs constantly in light of new medical technology. PAYMENT OF AMBULATORY PHYSICIANS IN GERMANY

Ambulatory‐care physicians are paid on a FFS basis, on a schedule of points per service which is then converted to monetary units through a conversion factor (€/point).

Until recently, this system operated within global budgets so that the €/point automatically fell if the budget was exceeded.

The fee schedules now have fixed Euro prices instead of points, but physicians are still subjects to budget caps on an individual basis. Services rendered beyond the cap are reimbursed at a much lower rate. State-based associations of sickness funds physicians negotiate annually with state-based associations of sickness funds over the overall aggregate payments to the physician sickness fund association (the Kassenärztliche Vereinigungen or KV). FFS WITHIN GLOBAL BUDGETS

Sickness Funds

Aggregate amount, based on risk- adjusted capitation per insured

Regional Sickness-Fund Physician Associations (Kassenärztliche Vereinigungen or KV)

Since 2009 adjusted for morbidity

GLOBAL BUDGET FOR GPs GLOBAL SPECIALIST BUDGET

FFS payment on point system subject to the global budgets.

General Practitioners Specialists PAYMENT FOR PRESCRIPTION DRUGS

Drug manufacturers in Germany can set their own wholesale prices.

The federal government regulates wholesale and retail mark-ups.

Sickness funds pay for prescription drugs on a reference-price system, coupled with rebates for on-patent drugs, which replaced earlier budget caps per prescribing physicians.

From 2011 on, the system is subject to comparative effectiveness analysis. A closer look at Swiss Health Care OVERVIEW Switzerland 7.5 million people live in 26 cantons, some of which are large cities, other small rural enclaves.

Health insurance is mandated in Switzerland, on a cantonal basis, but within an overarching federal health insurance law passed in 1996. There are few uninsured (about 1.5% of the population).

As in Germany, there are no government-run health insurance programs in Switzerland. All insured purchase coverage from private insurers that cannot earn profits on the mandated benefit package but may earn profits on supplemental insurance.

The health-care delivery system is a mixed system, as in Germany.

Governance of the system is highly decentralized, involving federal, cantonal and communal governments. SWITZERLAND’S HEALTH INSURANCE SYSTEM

Mandatory basic health insurance in Switzerland is regulated and supervised by the Federal Office of Public Health under the Federal Health Insurance Act of 1996. It covers about 43% of total national health spending. Long term care is not part of social insurance and is still paid largely privately out of pocket.

Nationwide there are over 80 private insurers, although not all of them sell insurance in every canton, and the 10 largest carriers cover 80 percent of the population.

For the mandated basic package – which excludes dental care -- insurers can vary the deductible from a minimum of CH300 to a maximum of CH2,500. In addition, a coinsurance rate of 10% applies to all but a few exempt services. Out of pocket spending therefore is very high in Switzerland (30% of total national health spending), although very low-income people receive subsidies from the cantons. SWITZERLAND’S HEALTH INSURANCE SYSTEM

Every insurer is free to set the premium for the mandated basic benefit package, but an insurer’s premium applies to all customers regardless of age or health status.

Because of guaranteed issue and community rated premiums, there is cantonal a risk equalization fund, but it relies on few variables (only age and gender, while Germany’s as well as the Dutch risk adjusters have over 80 morbidity variables) for risk adjustment and is judged far from satisfactory.

As a result, individual insurers in Switzerland have an incentive to cherry pick – not to earn profits (which is prohibited on the mandated package), but to be able to compete with lower premiums.

Low-income people in Switzerland receive public subsidies toward the purchase of health insurance. SWITZERLAND’S HEALTH INSURANCE SYSTEM

Because health insurance is decentralized on a cantonal basis, there are significant differences in health insurance premiums for identical benefit packages.

Remarkably, there remain large premium differences even within cantons – see the following slides from Rutten et al.. These variances are thought to reflect risk selection, rather than relative efficiency in purchasing health care and administering claims.

These intra-cantonal variances in premiums suggest that many Swiss citizens do not switch insurers in spite of these large differences. It reflects a bias for the status quo.

PAYMENT OF HOSPITALS IN SWITZERLAND

Hospitals, which can be public, private non-profit or private for profit receive about a third of their financing from the cantons, within a cantonal planning system.

Hospitals are paid by insurers either on a per diem or a DRG basis negotiated at the cantonal level.

As of 2012, hospitals are to be reimbursed on a nationwide DRG basis.

The cantonal governments absorb hospital deficits. PAYMENT OF PHYSICIANS IN SWITZERLAND

Switzerland has one of the highest physician-population ratios in the OECD (380 per 100,000 population)

As in Germany, hospital-based physicians are usually salaried.

Ambulatory-care physicians are paid on a FFS basis at fees that are negotiated on the cantonal level between associations of insurers and of physicians. PAYMENT FOR PRESCRIPTION DRUGS

Drug prices are regulated by the federal government in Switzerland. Comparative effectiveness is a factor in setting prices for drugs.

Generics must be sold at 50% of the corresponding brand-name drug; but only about 9% of drugs sold are generics (compared with close to 70% in the US)

Sickness funds pay for prescription drugs on a reference-price system, coupled with rebates for on-patent drugs, which replaced earlier budget caps per prescribing physicians.

From 2011 on, the system is subject to comparative effectiveness analysis. CONSLUSION ON THE GERMAN AND SWISS HEALTH-CARE SYSTEMS Both systems slouch in the direction of what we think of as “regulated or ‘managed’ competition” in the U.S.

Allowing citizens a choice among tightly regulated health insurers provides the illusion of competition, but it is just that, an illusion.

It is an illusion because the prices at which insurers buy health care for the insured are typically out of the insurer’s control.

Furthermore, there is virtually no ability to exclude providers with relatively low quality of services.

But perhaps there is value in the eyes of citizens in a system that provides the illusion that it is not a government-run health insurance system. Of the two systems, Germany’s is by far the more egalitarian system.

Germany’s health system also registers significantly lower costs on a PPP per capita basis.

Overall, though, the Swiss health system is generally viewed as one of the highest-quality health systems in the world – certainly outranking the United States on many dimensions. THE END